AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. SLN
  4. [Form 4] Silence Therapeutics Plc American Depository Share Insider Trading Activity

[Form 4] Silence Therapeutics Plc American Depository Share Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Filing content is currently unavailable.

Source:

Stock SLN logo
Silence Therapeutics Plc

NASDAQ:SLN

SLN Rankings

#3965 Ranked by Market Cap
N/A Ranked by Dividends

SLN Latest News

Aug 7, 2025
Silence Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights
Jun 12, 2025
Silence Therapeutics Presents Additional Phase 1 Data Highlighting Promise of Divesiran as the Potential First-in-Class siRNA Treatment for Polycythemia Vera
May 8, 2025
Silence Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights
May 6, 2025
Silence Therapeutics Welcomes Tim McInerney to Board of Directors
Mar 5, 2025
Silence Therapeutics to Webcast Presentation at the Leerink Partners Global Healthcare Conference

SLN Latest SEC Filings

Aug 7, 2025
[10-Q] Silence Therapeutics Plc American Depository Share Quarterly Earnings Report
Aug 7, 2025
[8-K] Silence Therapeutics Plc American Depository Share Reports Material Event
Aug 4, 2025
[Form 4] Silence Therapeutics Plc American Depository Share Insider Trading Activity
Jul 31, 2025
[Form 4] Silence Therapeutics Plc American Depository Share Insider Trading Activity
Jul 23, 2025
[Form 4] Silence Therapeutics Plc American Depository Share Insider Trading Activity

SLN Stock Data

238.04M
34.57M
24.38%
48.85%
1.95%
Biotechnology
Pharmaceutical Preparations
United Kingdom
LONDON